Yazar "Moiseenko, Fedor Vladimirovich" seçeneğine göre listele
Listeleniyor 1 - 1 / 1
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met-overexpressing (OE) advanced non-small cell lung cancer (NSCLC).(Lippincott Williams & Wilkins, 2022) Camidge, D. Ross; Bar, Jair; Horinouchi, Hidehito; Goldman, Jonathan W.; Moiseenko, Fedor Vladimirovich; Filippova, Elena; Cicin, Irfan[Abstract Not Available]
